FINWIRES · TerminalLIVE
FINWIRES

Research Alert: Lyv Faces Uncertainty With Antitrust Court Decision On Ticketmaster

-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:

LYV received a U.S. court jury's verdict late yesterday awarding $1.72/ticket in damages (est. $700M) after determining LYV monopolized ticketing services, concert ticketing, and concert venue markets. Our legal analyst at Washington Analysis, CFRA's policy business, sees 20% odds of a company breakup. We see the DOJ accepting the efficacy of the terms of settlement it reached with LYV, although we may see LYV appeal the jury's decision. There could be a post-trial motion to cut back the verdict by Judge Subramanian, as indicated from significant issues raised by LYV that argued the states' lawsuits failed to establish factual support on harm to competition and damages to the public. LYV's motion to exclude the states' damages expert is already briefed and Judge Subramanian could decide it soon. Washington Analysis says that state attorney generals may have strong incentives to settle, creating another news cycle about how they took it to LYV and delivered ticket savings to consumers. We keep our Hold view.

Related Articles

Asia

Shakti Pumps (India) Invests INR100 Million in EV Mobility Unit

Shakti Pumps (India) (NSE:SHAKTIPUMP, BOM:531431) said it has invested 100 million Indian rupees in its wholly owned subsidiary Shakti EV Mobility by subscribing to 10 million equity shares, according to a Tuesday filing to the Indian stock exchanges.Shares of the company rose 1% in Wednesday's trade.With this, Shakti Pumps' total investment in the EV mobility unit has increased to 650 million Indian rupees, the filing said.The investment is aimed at supporting business expansion of the subsidiary, it added.

$BOM:531431$NSE:SHAKTIPUMP
Asia

Challenger's Fiscal 2026 Q3 Update Missed Consensus Across Key Life Metrics, Jarden Says

Challenger's (ASX:CGF) fiscal 2026 third-quarter update missed consensus across key Life metrics, with FM outflows significantly worse than expected, driven by institutional equity mandate attrition in both Australian and global equities, according to a Tuesday note by Jarden.The firm's redemption of all CGFPC notes on May 25 simplifies the capital structure, reduces the AT1 coupon burden, and is earnings-per-share accretive.Jarden sees balanced risk/reward for Challenger in the future, with catalysts including capital management flexibility from the Australian Prudential Regulation Authority reform, as well as expanding retirement partnerships across superfunds.It lowered its fiscal 2026 sales forecast to reflect weaker institutional fixed-term sales, partially offset by higher retail annuity sales as partnerships come online.The investment firm retained its neutral rating on Challenger and raised the price target to AU$8.70 per share from AU$8.60 per share.

$ASX:CGF
Asia

Proya Cosmetics 2025 Profit Down 4%, Revenue Slips 2%

Proya Cosmetics (SHA:603605) posted 2025 attributable net profit of 1.50 billion yuan, down 3.5% from 1.55 billion yuan the previous year.Earnings per share slid to 3.80 yuan from 3.92 yuan, according to a Wednesday filing with the Shanghai bourse.Operating revenue declined 1.7% year over year to 10.6 billion yuan from 10.8 billion yuan.Shares of the cosmetics maker were up over 1% in recent trade.

$SHA:603605